Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Recruiting · NCT05804370 · Registry updated 2026-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 3 | 2026-07-14 | NCT05804370 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NX Development Corp | 2 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CAMC Institute for Academic Medicine - Cancer Research Center | Charleston | United States | 1 |
| Luminis Health Anne Arundel Medical Center | Annapolis | United States | 31 |
| Mayo Clinic Arizona | Phoenix | United States | 55 |
| Mayo Clinic Florida | Jacksonville | United States | 105 |
| Mayo Clinic Methodist Campus | Rochester | United States | 1 |
| Mount Sinai | New York | United States | 1 |
| Riverside Health | Newport News | United States | 1 |
| The Cleveland Clinic Foundation | Cleveland | United States | 55 |
| University of Maryland | Baltimore | United States | 86 |
| WellSpan Health | York | United States | 11 |
| WVU Cancer Institute | Morgantown | United States | 2 |